I still own it as one of the original biotech portfolios I build, but have never added to it and the position is down at least 30% for me.
They are a group of "evil", but the investment thesis is their expertise in pain medicine possibly combined with their synthetic cannabinoids could produce a efficacious pain medicine for the FDA approved drug only type patients and doctors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.